The DOI matches its Crossref record; 137 of the 138 references it cites were found in a registry or an index.
Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
Open accessAbstract
Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS), increase as the population ages around the world. Environmental factors also play an important role in most cases. Alcohol consumption exists extensively and it acts as one of the environmental factors that promotes these neurodegenerative diseases. The brain is a major target for the actions of alcohol, and heavy alcohol consumption has long been associated with brain damage. Chronic alcohol intake leads to elevated glutamate-induced excitotoxicity, oxidative stress and permanent neuronal damage associated with malnutrition. The relationship and contributing mechanisms of alcohol with these three diseases are different. Epidemiological studies have reported a reduction in the prevalence of Alzheimer’s disease in individuals who drink low amounts of alcohol; low or moderate concentrations of ethanol protect against β-amyloid (Aβ) toxicity in hippocampal neurons; and excessive amounts of ethanol increase accumulation of Aβ and Tau phosphorylation. Alcohol has been suggested to be either protective of, or not associated with, PD. However, experimental animal studies indicate that chronic heavy alcohol consumption may have dopamine neurotoxic effects through the induction of Cytochrome P450 2E1 (CYP2E1) and an increase in the amount of α-Synuclein (αSYN) relevant to PD. The findings on the association between alcohol consumption and ALS are inconsistent; a recent population-based study suggests that alcohol drinking seems to not influence the risk of developing ALS. Additional research is needed to clarify the potential etiological involvement of alcohol intake in causing or resulting in major neurodegenerative diseases, which will eventually lead to potential therapeutics against these alcoholic neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The role of CYP2E1 in brain ethanol metabolism and its association with alcohol-mediated oxidative neuronal injury155–160 and aging-related AD and PD161 have also been suggested.”
From Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury (2021) · cites this paper as [161]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Renaud, S., & de Lorgeril, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91277-f · Cited by 3,700
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
The epidemiology of Parkinson's disease: risk factors and prevention
Ascherio, A., & Schwarzschild, M. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30230-7 · Cited by 1,930
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261
Ageing, neurodegeneration and brain rejuvenation
Wyss-Coray, T. (2016) · Nature · doi:10.1038/nature20411 · Cited by 1,147
The epidemiology of ALS: a conspiracy of genes, environment and time
Al‐Chalabi, A., & Hardiman, O. M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.203 · Cited by 984
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804
Incidence of amyotrophic lateral sclerosis in Europe
Logroscino, G., Traynor, B. J., Hardiman, O., Chio, A., Mitchell, D., Swingler, R. J., Millul, A., Benn, E., Beghi, E., & EURALS, F. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.183525 · Cited by 772
Epidemiology of amyotrophic lateral sclerosis: an update of recent literature
Longinetti, E., & Fang, F. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000730 · Cited by 620
Meta-analysis of modifiable risk factors for Alzheimer's disease
Xu, W., Tan, L., Wang, H.-F., Jiang, T., Tan, M.-S., Tan, L., Zhao, Q.-F., Li, J.-Q., Wang, J., & Yu, J.-T. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310548 · Cited by 573
van der Kolk, N. M., de Vries, N. M., Kessels, R. P. C., Joosten, H., Zwinderman, A. H., Post, B., & Bloem, B. R. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30285-6 · Cited by 565
Alcohol consumption and risk of dementia: the Rotterdam Study
Ruitenberg, A., Swieten, J. C. V., Witteman, J. C. M., Mehta, K. M., van Duijn, C. M., Albert Hofman, D., & Breteler, M. M. B. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07493-7 · Cited by 549
Parkinson's Disease and the Environment
Ball, N., Teo, W., Chandra, S., & Chapman, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00218 · Cited by 521
Prospective Study of Alcohol Consumption and Risk of Dementia in Older Adults
Mukamal, K. J., Kuller, L. H., Fitzpatrick, A. L., Longstreth, W. T., Mittleman, M. A., & Siscovick, D. S. (2003) · JAMA · doi:10.1001/jama.289.11.1405 · Cited by 517
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990
Bower, J. H., Maraganore, D. M., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.52.6.1214 · Cited by 509
Davies, M. J., Baer, D. J., Judd, J. T., Brown, E. D., Campbell, W. S., & Taylor, P. R. (2002) · JAMA · doi:10.1001/jama.287.19.2559 · Cited by 459
Anstey, K. J., Mack, H. A., & Cherbuin, N. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181a2fd07 · Cited by 452
Binge drinking: Health impact, prevalence, correlates and interventions
Kuntsche, E. N., Kuntsche, S., Thrul, J., & Gmel, G. E. (2017) · Psychology and Health · doi:10.1080/08870446.2017.1325889 · Cited by 407
Effects of Moderate Alcohol Consumption on Cognitive Function in Women
Stampfer, M. J., Kang, J. H., Chen, J., Cherry, R., & Grodstein, F. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041152 · Cited by 396
Checkoway, H., Powers, K. M., Smith‐Weller, T., Franklin, G. M., Longstreth, W. T., & Swanson, P. D. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.8.732 · Cited by 371
Guerri, C., & Pascual, M. (2010) · Alcohol · doi:10.1016/j.alcohol.2009.10.003 · Cited by 357
Alcohol Intake and Risk of Dementia
Luchsinger, J. A., Tang, M., Siddiqui, M., Shea, S., & Mayeux, R. P. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52159.x · Cited by 349
Hersi, M., Irvine, B., Gupta, P., Gomes, J., Birkett, N., & Krewski, D. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.006 · Cited by 332
Xu, L., Liu, T., Liu, L., Yao, X., Chen, L., Fan, D., Zhan, S., & Wang, S. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09652-y · Cited by 330
Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis
D’Amico, E., Factor-Litvak, P. R., Santella, R. M., & Mitsumoto, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.029 · Cited by 328
Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study
Dick, F. D., Palma, G. D., Ahmadi, A., SCOTT, N. W., Prescott, G. J., Bennett, J. B., Semple, S. E., Dick, F. D., Counsell, C. E., Mozzoni, P., et al. (2007) · Occupational and Environmental Medicine · doi:10.1136/oem.2006.027003 · Cited by 326
Anttila, T., Helkala, E.-L., Viitanen, M., Kåreholt, I., Fratiglioni, L., Winblad, B., Soininen, H., Tuomilehto, J., Nissinen, A., & Kivipelto, M. (2004) · BMJ · doi:10.1136/bmj.38181.418958.be · Cited by 323
Coffee and tea consumption and the risk of Parkinson's disease
Hu, G., Bidel, S., Jousilahti, P., Antikaínen, R., & Tuomilehto, J. O. (2007) · Movement Disorders · doi:10.1002/mds.21706 · Cited by 286
Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study
Sabia, S., Fayossé, A., Dumurgier, J., Dugravot, A., Akbaraly, T. N., Britton, A. R., Mika Kivimaki, B., & Singh‐Manoux, A. (2018) · BMJ · doi:10.1136/bmj.k2927 · Cited by 286
Sierksma, A., van der Gaag, M., Kluft, C., & Hendriks, H. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601459 · Cited by 231 · cited 2×
“In addition, alcohol can increase insulin sensitivity [24], stimulate fibrinolysis [25], oppose thrombin activity [26], prevent platelet aggregation [27] and reduce inflammatory markers [28].”
BackgroundEpidemiology of Parkinson's Disease—East Versus West
Abbas, M. M., Xu, Z., & Tan, L. C. S. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12568 · Cited by 204
Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade
Marras, C., Canning, C. G., & Goldman, S. M. (2019) · Movement Disorders · doi:10.1002/mds.27720 · Cited by 199
Tan, L. C. S., Koh, W., Yuan, J., Wang, R., Au, W., Tan, J.-H., Tan, E., & Yu, M. C. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm338 · Cited by 190
Anstey, K. J., Ee, N., Eramudugolla, R., Jagger, C., & Peters, R. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190181 · Cited by 187
Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress
Akbar, M. D., Essa, M. M., Daradkeh, G., Abdelmegeed, M. A., Choi, Y., Mahmood, L., & Song, B. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.016 · Cited by 182
Self-citationPathophysiology of the Effects of Alcohol Abuse on the Endocrine System
Rachdaoui, N. (2017) · Alcohol research · doi:10.35946/arcr.v38.2.08 · Cited by 180
Nelson, L. M., McGuire, V., Longstreth, W. T., & Matkin, C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010183 · Cited by 174
Risk factors for parkinson’s disease: The leisure world cohort study
Paganini-Hill, A. (2001) · Neuroepidemiology · doi:10.1159/000054770 · Cited by 159
Drew, P. D., Johnson, J. W., Douglas, J. C., Phelan, K. D., & Kane, C. J. M. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12639 · Cited by 154
Simpson, R. F., Hermon, C., Liu, B., Green, J., Reeves, G. K., Beral, V., & Floud, S. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30230-5 · Cited by 154
The association between lifestyle factors and Parkinson's disease progression and mortality
Paul, K. C., Chuang, Y., Shih, I., Keener, A. M., Bordelon, Y. M., Bronstein, J. M., & Ritz, B. R. (2019) · Movement Disorders · doi:10.1002/mds.27577 · Cited by 150
Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study
Kioumourtzoglou, M.-A., Rotem, R. S., Seals, R. M., Gredal, O., Hansen, J., & Weisskopf, M. G. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0910 · Cited by 145
Risk and protective factors for Parkinson's disease: A study in Swedish twins
Wirdefeldt, K., Gatz, M., Yudi Pawitan, Y., & Pedersen, N. L. (2004) · Annals of Neurology · doi:10.1002/ana.20307 · Cited by 144
Kaut, O., Schmitt, I., & Wüllner, U. (2012) · Neurogenetics · doi:10.1007/s10048-011-0308-3 · Cited by 138
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
Schirinzi, T., Martella, G., Imbriani, P., Lazzaro, G. D., Franco, D., Colona, V. L., Al-Wardat, M. S., Salimei, P. S., Mercuri, N. B., Pierantozzi, M., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00148 · Cited by 138
Rees, K., Stowe, R. L., Patel, S., Ives, N. J., Breen, K. C., Clarke, C. E., & Ben‐Shlomo, Y. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008454 · Cited by 130
Occupational pesticide use and Parkinson's disease in the Parkinson Environment Gene (PEG) study
Narayan, S., Liew, Z., Bronstein, J. M., & Ritz, B. R. (2017) · Environment International · doi:10.1016/j.envint.2017.04.010 · Cited by 127
Alcohol consumption and incidence of dementia in a community sample aged 75 years and older
Huang, W., Qiu, C., Winblad, B. G., & Fratiglioni, L. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00462-6 · Cited by 125
Association between Bone Mineral Density and the Risk of Alzheimer's Disease
Zhou, R., Deng, J., Zhang, M., Zhou, H.-D., & Wang, Y.-J. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101467 · Cited by 123 · cited 1×
“, 2011 [56] Populationbased Cohort 172/3170 DSM-IV Criteria Age, BMI, education, APOE4, vascular risk Factors Occasional drinking; Monthly drinking; Weekly drinking; Daily drinking 1 1.”
BackgroundIntake of dairy foods and risk of Parkinson disease
Hughes, K. C., Gao, X., Kim, I. Y., Wang, M., Weisskopf, M. G., Schwarzschild, M. A., & Ascherio, A. (2017) · Neurology · doi:10.1212/wnl.0000000000004057 · Cited by 123
Rees, K., Stowe, R. L., Patel, S., Ives, N. J., Breen, K. C., Clarke, C. E., & Ben‐Shlomo, Y. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008454.pub2 · Cited by 122
de Jong, S. W., Huisman, M. H. B., Sutedja, N. A., van der Kooi, A. J., de Visser, M., Schelhaas, H. J., Fischer, K., Veldink, J. H., & van den Berg, L. H. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws015 · Cited by 117
Roberts, B. J., Shoaf, S. E., Jeong, K. S., & Song, B. J. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2774 · Cited by 116
Self-citationLangballe, E. M., Ask, H., Holmen, J., Stordal, E., Saltvedt, I. T., Selbæk, G., Fikseaunet, A., Bergh, S., Nafstad, P. H. J., & Tambs, K. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0029-2 · Cited by 115
Weyerer, S. B., Schäufele, M., Wiese, B., Maier, W., Tebarth, F., van den Bussche, H., Pentzek, M., Bickel, H., Luppa, M., Riedel-Heller, S. G., et al. (2011) · Age and Ageing · doi:10.1093/ageing/afr007 · Cited by 115
Hoffman, J. L., Faccidomo, S., Kim, M., Taylor, S. M., Agoglia, A. E., May, A. M., Smith, E. N., Wong, L. C., & Hodge, C. W. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.017 · Cited by 113
Patrick, K. L., Bell, S. L., Weindel, C. G., & Watson, R. O. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00138 · Cited by 110
Karkhanis, A. N., Rose, J. H., Huggins, K. N., Konstantopoulos, J. K., & Jones, S. R. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.019 · Cited by 108
Risk factors and emerging therapies in amyotrophic lateral sclerosis
Nowicka, N., Juranek, J., Juranek, J. K., & Wojtkiewicz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112616 · Cited by 106
Huisman, M. H. B., Seelen, M., van Doormaal, P. T. C., de Jong, S. W., de Vries, J. H. M., van der Kooi, A. J., de Visser, M., Schelhaas, H. J., van den Berg, L. H., & Veldink, J. H. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1584 · Cited by 103
Dietary fats, cholesterol and iron as risk factors for Parkinson's disease
Powers, K. M., Smith-Weller, T., Franklin, G. M., Longstreth, W. T., Swanson, P. D., & Checkoway, H. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.03.002 · Cited by 100
Association of Cigarette Smoking with Amyotrophic Lateral Sclerosis
Kamel, F., Umbach, D. M., Munsat, T. L., Shefner, J. M., & Sandler, D. P. (1999) · Neuroepidemiology · doi:10.1159/000026211 · Cited by 100
Plant-derived neuroprotective agents in Parkinson's disease.
Fu, W., Zhuang, W., Zhou, S., & Wang, X. (2015) · Europe PMC (PubMed Central) · Cited by 98
Self-citationAlcohol intake and risk of Parkinson's disease: A meta‐analysis of observational studies
Zhang, D., Jiang, H. F., & Xie, J. (2014) · Movement Disorders · doi:10.1002/mds.25863 · Cited by 96
Alcohol, aging, and innate immunity
Boulé, L. A., & Kovacs, E. J. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ru1016-450r · Cited by 94
The Role of CYP2E1 in Alcohol Metabolism and Sensitivity in the Central Nervous System
Heit, C., Dong, H., Chen, Y., Thompson, D. C., Deitrich, R. A., & Vasiliou, V. (2013) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5881-0_8 · Cited by 93
Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels
Sierksma, A., van der Gaag, M. S., Kluft, C., & Hendriks, H. F. J. (2001) · TNO Repository · Cited by 91
Luo, C., Yang, Q., Liu, Y., Zhou, S., Jiang, J., Reiter, R. J., Bhattacharya, P., Cui, Y., Yang, H. W., Ma, H., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.402 · Cited by 91
Self-citationGiorgio, F. D., Maduro, C., Fisher, E., & Acevedo‐Arozena, A. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.037424 · Cited by 91
Alcohol, microbiome, and their effect on psychiatric disorders
Hillemacher, T., Bachmann, O. P., Kahl, K. G., & Frieling, H. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.015 · Cited by 90
Alcohol consumption and the incidence of Parkinson's disease
Hernán, M. Á., Chen, H., Schwarzschild, M. A., & Ascherio, A. (2003) · Annals of Neurology · doi:10.1002/ana.10611 · Cited by 87
Chronic Neurologic Effects of Alcohol
Hammoud, N., & Shahed, J. J. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.09.010 · Cited by 85
Mendelian randomization of serum urate and parkinson disease progression
Simon, K. C., Eberly, S. W., Gao, X., Oakes, D., Tanner, C. M., Shoulson, I., Fahn, S., Schwarzschild, M. A., Ascherio, A., & on behalf of the Parkinson Study Group (2014) · Annals of Neurology · doi:10.1002/ana.24281 · Cited by 84
Alcohol-induced alterations in dopamine modulation of prefrontal activity
Trantham‐Davidson, H., & Chandler, L. J. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.09.001 · Cited by 82
Therapeutic neuroprotective agents for amyotrophic lateral sclerosis
Pandya, R. S., Zhu, H., Li, W., Bowser, R. P., Friedlander, R. M., & Wang, X. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1415-0 · Cited by 77
Self-citationSexual dimorphism in ALS: Exploring gender-specific neuroimaging signatures
Bede, P., Elamin, M., Byrne, S., & Hardiman, O. M. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.865749 · Cited by 76
Mechanism by which Alcohol and Wine Polyphenols Affect Coronary Heart Disease Risk
Booyse, F. M., Pan, W., Grenett, H. E., Parks, D. A., Darley-Usmar, V. M., Bradley, K. M., & Tabengwa, E. M. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.01.006 · Cited by 75
Tsitkanou, S., Gatta, P. A. D., Foletta, V. C., & Russell, A. P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00783 · Cited by 72
Ethanol Alters APP Processing and Aggravates Alzheimer-Associated Phenotypes
Huang, D., Yu, M., Yang, S., Lou, D., Zhou, W., Zheng, L., Wang, Z., Cai, F., Zhou, W., Li, T., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0703-3 · Cited by 70
Glutamate Transporter 1: Target for the Treatment of Alcohol Dependence
Rao, S., & Sari, Y. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803530511 · Cited by 69
Alcohol Consumption, Types of Alcohol, and Parkinson’s Disease
Liu, R., Guo, X., Park, Y., Wang, J., Huang, X., Hollenbeck, A. R., Blair, A. E., & Chen, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066452 · Cited by 66
Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women
Palacios, N., Gao, X., O’Reilly, É. J., Schwarzschild, M. A., McCullough, M. L., Mayo, T. L., Gapstur, S. M., & Ascherio, A. (2012) · Movement Disorders · doi:10.1002/mds.25050 · Cited by 62
Parkinson Disease and Melanoma
Dalvin, L. A., Damento, G. M., Yawn, B. P., Abbott, B. A., Hodge, D. O., & Pulido, J. S. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.03.014 · Cited by 62
Chen, D., Fu, W., Zhuang, W., Lv, C., Li, F., & Wang, X. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23879 · Cited by 61
Self-citationBrain ageing and neurodegenerative disease: The role of cellular waste management
Daniele, S., Giacomelli, C., & Martini, C. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.10.030 · Cited by 61
Eriksson, A.-K., Löfving, S., Callaghan, R. C., & Allebeck, P. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-190 · Cited by 60
Collins, M. A., Neafsey, E. J., Wang, K., Achille, N. J., Mitchell, R. M., & Sivaswamy, S. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8138-0 · Cited by 59
A prospective study of alcoholism and the risk of Parkinson?s disease
Hernán, M. Á., Logroscino, G., & guez, L. A. G. A. R. (2004) · Journal of Neurology · doi:10.1007/s00415-004-1705-4 · Cited by 58
Inhibition of amyloid-β-induced neurotoxicity and apoptosis by moderate ethanol preconditioning
Belmadani, A. A., Kumar, S., Schipma, M. J., Collins, M. A., & Neafsey, E. J. (2004) · Neuroreport · doi:10.1097/00001756-200409150-00019 · Cited by 57
Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Case-Control Study in Japan
Okamoto, K., Kihira, T., Kondo, T., Kobashi, G., Washio, M., Sasaki, S., Yokoyama, T., Miyake, Y., Sakamoto, N., Inaba, Y., et al. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.01.015 · Cited by 55
Impact of Coffee, Wine, and Chocolate Consumption on Cognitive Outcome and MRI Parameters in Old Age
Haller, S., Montandon, M., Rodriguez, C. K., Herrmann, F. R., & Giannakopoulos, P. (2018) · Nutrients · doi:10.3390/nu10101391 · Cited by 54
Is There an Association Between Low-to-Moderate Alcohol Consumption and Risk of Cognitive Decline?
Lobo, E., Dufouil, C., Marcos, G., Quetglas, B., Saz, P., Güallar, E., Lobo, A., & Workgroup, F. T. Z. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq187 · Cited by 52
Vinceti, M., Violi, F., Tzatzarakis, M. N., Mandrioli, J., Malagoli, C., Hatch, E. E., Fini, N., Fasano, A., Rakitskii, V. N., Kalantzi, O., et al. (2017) · Environmental Research · doi:10.1016/j.envres.2017.02.025 · Cited by 51
Seals, R. M., Hansen, J., Gredal, O., & Weisskopf, M. G. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv169 · Cited by 44
Low concentrations of ethanol protect against synaptotoxicity induced by Aβ in hippocampal neurons
Muñoz, G., Urrutia, J. C., Burgos, C. F., Silva, V., Aguilar, F., Sama, M. A., Yeh, H. H., Opazo, C., & Aguayo, L. G. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.017 · Cited by 41
A Population Perspective on Prevention of Dementia
Eggink, E., van Charante, E. P. M., van Gool, W. A., & Richard, E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060834 · Cited by 41
Hsp31 Is a Stress Response Chaperone That Intervenes in the Protein Misfolding Process
Tsai, C.-J., Aslam, K., Drendel, H. M., Asiago, J. M., Goode, K. M., Paul, L. N., Rochet, J., & Hazbun, T. R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.678367 · Cited by 40
Neuroprotective agents target molecular mechanisms of disease in ALS
Zhu, Y., Fotinos, A., Mao, L. L. J., Atassi, N., Zhou, E., Ahmad, S., Guan, Y., Berry, J. D., Cudkowicz, M., & Wang, X. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.016 · Cited by 39
Self-citationEthanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage
Bate, C., & Williams, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.030 · Cited by 38
Voluptuary habits and clinical subtypes of Parkinson's disease: The FRAGAMP case–control study
Nicoletti, A. S. Q., Pugliese, P., Nicoletti, G., Arabia, G., Annesi, G., Mari, M. D., Lamberti, P., Grasso, L., Marconi, R., Epifanio, A., et al. (2010) · Movement Disorders · doi:10.1002/mds.23297 · Cited by 38
Lee, P., Ahmed, I., Loriot, M., Mulot, C., Paul, K. C., Bronstein, J. M., Ritz, B. R., & Elbaz, A. (2018) · Neurology · doi:10.1212/wnl.0000000000004953 · Cited by 38
Cavaleri, F. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.10.009 · Cited by 36
Ginsenoside Rd and ginsenoside Re offer neuroprotection in a novel model of Parkinson's disease.
Zhang, X., Wang, Y., Ma, C., Yan, Y., Yang, Y., Wang, X., & Rausch, W. (2016) · Europe PMC (PubMed Central) · Cited by 36
Self-citationChronic mild stress augments MPTP induced neurotoxicity in a murine model of Parkinson's disease
Janakiraman, U., Manivasagam, T., Justin Thenmozhi, A., Dhanalakshmi, C., Essa, M. M., Song, B.-J., & Guillemin, G. J. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.01.046 · Cited by 36
Self-citationD’Ovidio, F., Rooney, J. P. K., Visser, A. E., Manera, U., Beghi, E., Logroscino, G., Vermeulen, R. C. H., Veldink, J. H., van den Berg, L. H., Hardiman, O. M., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318559 · Cited by 34
Peters, S., Visser, A. E., D'Ovidio, F., Vlaanderen, J., Portengen, L., Beghi, E., Chio, A., Logroscino, G., Hardiman, O., Pupillo, E., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-320986 · Cited by 33
α-Synuclein, alcohol use disorders, and Parkinson disease: A case–control study
Brighina, L., Schneider, N. K., Lesnick, T. G., de Andrade, M., Cunningham, J. M., Mrazek, D. A., Rocca, W. A., & Maraganore, D. M. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.11.011 · Cited by 32
Acetaldehyde and parkinsonism: role of CYP450 2E1
Vaglini, F., Viaggi, C., Valentina, P., Pardini, C., Gerace, C., Scarselli, M., & Corsini, G. U. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00071 · Cited by 31
Alcohol drinking and risk of Parkinson's disease: a case-control study in Japan
Fukuoka Kinki Parkinson's Disease Study Group, Fukushima, W., Miyake, Y., Tanaka, K., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., et al. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-111 · Cited by 30
Ethanol Reduces Amyloid Aggregation In Vitro and Prevents Toxicity in Cell Lines
Ormeño, D., Romero, F., Fenner, J. L., Ávila, A. I., Martínez‐Torres, A., & Parodí, J. (2013) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.12.004 · Cited by 29
Pandya, R. S., Mao, L. L. J., Zhou, E., Bowser, R. P., Zhu, Z., Zhu, Y., & Wang, X. (2012) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152412800229152 · Cited by 29
Self-citationLandau, A. M., Kouassi, É., Siegrist‐Johnstone, R., & Desbarats, J. (2007) · Movement Disorders · doi:10.1002/mds.21306 · Cited by 22
Alcohol intake patterns for cancer and non-cancer individuals: a population study
Lin, H., Fisher, P., Harris, D., & Tseng, T. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.06.31 · Cited by 21
Wang, X., Zhuang, W., Fu, W., Wang, X., Lv, E., Li, F., Zhou, S., Rausch, W., & Wang, X. (2018) · Europe PMC (PubMed Central) · Cited by 20
Self-citationPelkonen, A., Hiltunen, M. O., Kiianmaa, K., & Yavich, L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06844.x · Cited by 19
Ji, J., Sundquist, J., & Sundquist, K. (2015) · European Journal of Neurology · doi:10.1111/ene.12667 · Cited by 19
Hao, C., Liu, W. Y., Luan, X., Yang, L., Gui, H., Peng, Y., Shen, J., Hu, G., & Yang, J. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.06.023 · Cited by 19
Yang, Q., Luo, C., Zhang, X., Liu, Y., Wang, Z., Cacciamani, P., Shi, J., Cui, Y., Wang, C., Sinha, B., et al. (2020) · PubMed Central · Cited by 19
Self-citationEnhanced motivation to alcohol in transgenic mice expressing human α‐synuclein
Rotermund, C., Reolon, G. K., Leixner, S., Boden, C., Bilbao, A., & Kahle, P. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14151 · Cited by 16
Meng, E., Yu, S., Dou, J., Jin, W., Cai, X., Mao, Y., Zhu, D., & Yang, R. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2575-0 · Cited by 15
Neurological manifestations of excessive alcohol consumption
Planas-Ballvé, A., Grau‐López, L., Morillas, R. M., & Planas, R. (2017) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2017.11.001 · Cited by 15
Red Wine Extract Prevents Neuronal Apoptosis in Vitro and Reduces Mortality of Transgenic Mice
Amodio, R., Esposito, E., Ruvo, C. D., Bellavia, V., Amodio, E., & Carruba, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.026 · Cited by 13
Nyam, T.-T. E., Ho, C., Wang, Y., Lim, S.-W., Wang, J., Chio, C., Kuo, J., & Wang, C.-C. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.02.027 · Cited by 13
Toda, A., Tagata, Y., Nakada, T., Komatsu, M., Shibata, N., & Arai, H. (2013) · Psychogeriatrics · doi:10.1111/psyg.12008 · Cited by 12
Yu, L., Cherng, C.-F. G., & Chen, C. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200096 · Cited by 12
Fu, W., Zheng, Z., Zhuang, W., Chen, D., Wang, X., Sun, X., & Wang, X. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.814132 · Cited by 11
Self-citationChen, Y., Wang, Q., Wang, Q., Liu, H., Zhou, F., Zhang, Y., Yuan, M., Zhao, C., Guan, Y., & Wang, X. (2017) · PubMed Central · Cited by 10
Self-citationGushcha, V. K., Лелевич, С. В., & Шейбак, В. М. (2019) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20196501021 · Cited by 9
Low dose of alcohol attenuates pro-atherosclerotic activity of thrombin
Toda, M., Totoki, T., Nakamura, C., Yasuma, T., Alessandro‐Gabazza, C. N. D., Mifuji‐Moroka, R., Nishihama, K., Iwasa, M., Horiki, N., Esteban, G., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.09.005 · Cited by 8
J‐curve association between alcohol intake and varicose veins in Japan: The Shimane CoHRE Study
Kohno, K., Niihara, H., Hamano, T., Takeda, M., Nakagawa, Y., Shiwaku, K., Nabika, T., Zöller, B., Li, X., Sundquist, K., et al. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.15022 · Cited by 8
Amrani, A., Boubekri, N., Lassed, S., Zama, D., Benayache, F., & Benayache, S. (2017) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x17666170310101727 · Cited by 7
Red wine but not ethanol at low doses can protect against the toxicity of methamphetamine
Ali, S. F., & Bondy, S. C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.058 · Cited by 4
Acute parkinsonism in alcohol withdrawal: A case report
Chen, G.-C., & Wang, H. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.046 · Cited by 2
Flagged first, then by citations
1 of the 138 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Rungratanawanich, W., Qu, Y., Wang, X., Essa, M. M., & Song, B.-J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00561-7 · Cited by 411
Self-citationMelatonin and Autophagy in Aging-Related Neurodegenerative Diseases
Luo, F., Sandhu, A. F., Rungratanawanich, W., Williams, G. E., Akbar, M. D., Zhou, S., Song, B., & Wang, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197174 · Cited by 162
Self-citationPervin, Z., & Stephen, J. M. (2021) · AIMS neuroscience · doi:10.3934/neuroscience.2021021 · Cited by 110
Hop, P. J., Zwamborn, R. A. J., Hannon, E. J., Shireby, G. L., Nabais, M. F., Walker, E., van Rheenen, W., van Vugt, J. J. F. A., Dekker, A. M., Westeneng, H., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj0264 · Cited by 103
Evaluation of two different Cannabis sativa L. extracts as antioxidant and neuroprotective agents
Cásedas, G., Moliner, C., Maggi, F., Mazzara, E., & López, V. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1009868 · Cited by 56
Metadata
- Authors
- Peng, B., Yang, Q., B Joshi, R., Liu, Y., Akbar, M., Song, B.-J., Zhou, S., & Wang, X.
- Affiliations
- Brigham and Women's Hospital (US)
- Hubei Provincial Key Lab for Quality and Safety of Traditional Chinese Medicine Health Food, Jing Brand Research Institute, Daye 435100, China
- Departments of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
- National Institutes of Health (US)
- Corresponding author
- Zhou, Shuanhu
- Wang, Xin
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-03-27
- Volume
- 21
- Issue
- 7
- Pages
- 2316
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7177420
- OpenAlex
- W3013624048
- Cited by
- 156
- References
- 138
- Citations by year
- 2026: 13 · 2025: 38 · 2024: 34 · 2023: 30 · 2022: 24 · 2021: 15 · 2020: 2
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Brigham and Women's Hospital
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
- Keywords
- alcohol consumption, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, ethanol, amyloid-beta, tau phosphorylation, excitotoxicity, oxidative stress, dopamine neurotoxicity, CYP2E1, alpha-synuclein, environmental risk factors
- MeSH terms
- Alcohol Drinking, Ethanol, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Animals, Brain, Cell Line, Humans, Neurons, Parkinson Disease, Risk Factors, Amyloid beta-Peptides, Oxidative Stress, Disease Progression, Neurodegenerative Diseases, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
